- Datum03.07.2025
- Uhrzeit12:30 - 12:50 Uhr
- Veranstalter
UniCredit
Kein Moderator verfügbar
WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083 Aktie
Verkaufen
Kaufen
WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083 Chart
Echtzeit-News zu diesem und anderen Unternehmen findest Du hier!
Live-Ticker WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083 Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (L&S)
0,51 %
Intraday
2,94 %
1 Woche
0,71 %
1 Monat
29,24 %
Seit Jahresbeginn
104,08 %
1 Jahr
-68,42 %
3 Jahre
Passender Service zu WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083
Webinar zu WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083
Kursinformationen (L&S)
- Tagestief / Hoch (€)-
- 52W-Tief / Hoch (€)1,153-3,356
- Jahrestief / Hoch (€)1,946-3,356
- Schlusskurs (Vortag)
- Eröffnungskurs
Wichtigste Eigenschaften
Dividenden von WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083
Keine Dividenden verfügbar
Termine von WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083
- Aug25WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083Q2 2025 Earnings Release
- Mär31WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083Q4 2025 Earnings Release
- Aug24WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083Q2 2026 Earnings Release
Beschreibung
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.
